CASE DISCUSSION
Novel Biomarkers in Sepsis
Presented from United Arab Emirates by Dr. Adel Mohamed Yasin Al Sisi0
Likes
2294
Views
92
Shares
115
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Elevated levels of PCT serve as a valuable biomarker in sepsis, aiding in the early diagnosis and monitoring of bacterial infections, and guiding therapeutic decisions. CRP is a commonly used biomarker for inflammation, and its levels are frequently elevated in sepsis, providing clinicians with an...
Case Summary
- Sepsis definition has evolved, moving from SIRS criteria to a dysregulated immune response to infection leading to organ dysfunction. Early identification and immediate action are crucial, focusing on the first hour after suspected sepsis, emphasizing clinical assessment, blood tests, and organ support. Clinical evaluation remains critical, along with laboratory tests and organ function support, highlighting the importance of early management and risk stratification.
Speaker Profile
Dr. Adel Mohamed Yasin Al Sisi
Critical care Specialist,Prime Hospitals, DubaiHe has his expertise in critical care and emergency medicine with over 16 years of experience in dealing with acutely ill patients. Additionally he is an international reviewer of ICU articles and Participated as an author in ICU textbooks. He has in interest in Endotracheal and Nasotracheal intubation, use of mechanical ventilation , Insertion of Central Venous and Arterial access , Tapping of pleural effusion- Paracentesis , Pericardiocentesis , use of DC electrical shocks either in Advanced Cardiac Life Support or in the management of tachyarrhythmias.